| 摘要 |
The disclosure is directed to a method of treating a gastrointestinal condition in a mammal comprising administering a non-glyceryl ester of a lon g chain fatty acid or a bismuth component and a long chain fatty acid componen t. The long chain fatty acid ester is selected from the group consisting of lauric acid, lauroleic, myristic, myristoleic, pentadecanoic, palmitic, palmitoleic, margaric, stearic, dihydroxystearic, oleic, ricinoleic, elaidic , linoleic, alpha-linoleic, dihomogamma-linoleic, eleostearic, licanic, arachidonic, arachidic, eicosenoic, eicosapentaenoic, behenic, erucic, docosahexaenoic or lignoceric acid, and mixtures thereof, and the gastrointestinal condition is selected from the group consisting of diarrhea , rapid intestinal transit, dumping syndrom, weight loss, distention, steatorrhea, malnutrition, postgastrectomy syndrom, short bowel syndrom, Chron~s disease, gastrointestinal peptide tumors, irritable bowel syndrom, irritable bowel disease, abdominal pain, abdominal cramping, and combination s thereof. Ethyl alcate is the preferred compound.
|
